by Neoteryx, on April 19,2022
April 2022 — Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland (UQ) to develop a portable skin microbiopsy device that takes tissue samples smaller …
Read Storyby Neoteryx, on January 11,2022
January 2022 – As announced by Trajan Group Holdings Limited (ASX: TRJ) in early January from their headquarters in Australia, the company has acquired microsampling leader Neoteryx LLC. As reported …
Read Storyby Neoteryx, on October 20,2020
October 2020 — Alcohol-related death statistics around the world are staggering. Numbers from the World Health Organization (WHO) reveal that each year, approximately three million people around the globe die …
Read Storyby Christa Nuber, on August 25,2020
LOS ANGELES—Neoteryx announces the launch of an international Lab Directory on its neoteryx.com website. As a medical device company specializing in the remote collection of bio fluids with its Mitra® …
Read StoryThe latest product releases, company news and microsampling industry updates from Neoteryx.
If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
Fact Sheet & FAQs
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.